NH7 Stock Overview
Netcare Limited, an investment holding company, operates private hospitals in South Africa.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
Netcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R0.51 |
52 Week High | R0.78 |
52 Week Low | R0.50 |
Beta | 0.33 |
1 Month Change | -14.29% |
3 Month Change | -16.39% |
1 Year Change | -22.32% |
3 Year Change | -35.44% |
5 Year Change | -63.04% |
Change since IPO | -58.90% |
Recent News & Updates
Recent updates
Shareholder Returns
NH7 | DE Healthcare | DE Market | |
---|---|---|---|
7D | -2.9% | -1.8% | 1.6% |
1Y | -22.3% | -2.3% | 6.4% |
Return vs Industry: NH7 underperformed the German Healthcare industry which returned -2% over the past year.
Return vs Market: NH7 underperformed the German Market which returned 6.4% over the past year.
Price Volatility
NH7 volatility | |
---|---|
NH7 Average Weekly Movement | 9.7% |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NH7's share price has been volatile over the past 3 months.
Volatility Over Time: NH7's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 18,000 | Richard Friedland | https://www.netcare.co.za |
Netcare Limited, an investment holding company, operates private hospitals in South Africa. The company operates through Hospital and Emergency Services, and Primary Care segments. The Hospital and Emergency Services segment engages in the hospital and pharmacy operations.
Netcare Limited Fundamentals Summary
NH7 fundamental statistics | |
---|---|
Market cap | €752.83m |
Earnings (TTM) | €61.37m |
Revenue (TTM) | €1.16b |
12.3x
P/E Ratio0.7x
P/S RatioIs NH7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NH7 income statement (TTM) | |
---|---|
Revenue | R23.70b |
Cost of Revenue | R11.94b |
Gross Profit | R11.76b |
Other Expenses | R10.51b |
Earnings | R1.26b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 20, 2024
Earnings per share (EPS) | 0.96 |
Gross Margin | 49.63% |
Net Profit Margin | 5.30% |
Debt/Equity Ratio | 66.2% |
How did NH7 perform over the long term?
See historical performance and comparison